Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease

European Journal of Heart Failure

Volumn 14, Issue 5, 2012, Pages 530-539

  Koch, Michael ^a,b   Haastert, Burkhard ^c   Kohnle, Matthias ^a   Rump, Lars Christian ^b   Kelm, Malte ^b   Trapp, Rudolf ^a   Aker, Sendogan ^a  

^a Nephrologisches Zentrum Mettmann   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MediStatistica ^*  (Germany)

Author keywords

Chronic kidney disease; Heart failure; Impaired renal function; Mortality; Peritoneal dialysis

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT; UREA;

ADULT; AGE; AGED; ARTICLE; BODY WEIGHT; CATHETER COMPLICATION; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; DIABETES MELLITUS; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; UREA BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NEW YORK; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860356840     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs035     Document Type: Article

References (45)

1. Ronco C, Chionh C, Haapio M, Anavekar NS, House A, Bellomo R. The cardiorenal syndrome. Blood Purif 2009;27:114-126.
2. Cadnapaphornchai MA, Gurevich AK, Weinberger HD, Schrier RW. Pathophysiology of sodium and water retention in heart failure. Cardiology 2001;96:122-131.
3. Gil P, Justo S, Castilla MA, Criado C, Caramelo C. Cardio-renal insufficiency: the search for management strategies. Curr Opin Nephrol Hypertens 2005;14:442-447.
4. Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol 2005;95:8B-13B.
5. Alpert MA, Huting J, Twardowski ZJ, Khanna R, Nolph KD. Continuous ambulatory peritoneal dialysis and the heart. Perit Dial Int 1995;15:6-11.
6. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589-596.
7. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009;53:582-588.
8. Gotloib L, Fudin R, Yakubovich M, Vienken J. Peritoneal dialysis in refractory endstage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 2005;20 Suppl 7:vii32-vii36.
9. Ryckelink JP, Lobbedez T, Valette B, Le Goff C, Mazouz O, Levaltier B, Potier JC, Hurault de Ligny B. Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant 1998;13[Suppl 4]:56-59.
10. Elhalel-Dramtzki M, Rubinger D, Moscovici A, Haviv YS, Friedlaender MM, Silver J, Popovtzer MM. CAPD to improve quality of life in patients with refractory heart failure. Nephrol Dial Transplant 1998;13:3041-3042.
11. Basile C, Chimienti D, Bruno A, Cocola S, Libutti P, Teutonico A, Cazzato F. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure. Perit Dial Int 2009;29:116-118.
12. Kleinbaum DG, Klein M. Survival Analysis. 2nd ed. New York: Springer; 2005.
13. Sterne JAC, White IA, Carlin JB, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;29:338.
14. White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med 2009;28:1982-1998.
15. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987.
16. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006;47:1987-1996.
17. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-1009.
18. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation 2004;110:1514-1517.
19. Cnossen TT, Kooman JP, Konings CJ, Uszko-Lencer NH, Leunissen KM, van der Sande FM. Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure Blood Purif 2010;30:146-152.
20. Sanchez JE, Ortega T, Rodriguez C, D́az-Molina B, Mart́n M, Garcia-Cueto C, Vidau P, Gago E, Ortega F. Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 2010;25:605-610.
21. Smith GL, Shlipak MG, Havranek EP, Masoudi FA, McClellan WM, Foody JM, Rathore SS, Krumholz HM. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 2005;111:1270-1277.
22. Hillege HL, Girbes ARJ, de Kam PJ, Boomsma F, Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-210.
23. Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, van Veldhuisen DJ, Hillege HL. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 2007;13:599-608.
24. Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, Murray SA, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker SD, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J; Advanced Heart Failure Study Group of the HFA of the ESC. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11:433-443.
25. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149:209-216.
26. Zannad F, Mebazaa A, Juillière Y, Cohen-Solal A, Guize L, Alla F, Rougé P, Blin P, Barlet MH, Paolozzi L, Vincent C, Desnos M, Samii K. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 2006;8:697-705.
27. Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ, Dargie HJ; CIBIS-2 Investigators and Committees. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 2010;12:974-982.
28. Shilo S, Slotki IN, Iaina A. Improved renal function following acute peritoneal dialysis in patients with intractable congestive heart failure. Isr J Med Sci 1987;23: 821-824.
29. Sheppard R, Panyon J, Pohwani AL, Kapoor A, Macgowan G, McNamara D, Mathier M, Johnston JR, Murali S. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 2004;10: 380-383.
30. Agostoni P, Marenzi G, Lauri G, Perego G, Schianni M, Sganzerla P, Guazzi MD. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994;96:191-199.
31. Ahmed A, Husain A, Love TE, Gambassi G, Dell'Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 2006;27:1431-1439.
32. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Wang Y, Young JB, Krumholz HM. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004;147:331-338.
33. Ronco C, Ricci Z, Bellomo R, Bedogni F. Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology 2001;96: 155-168.
34. Giglioli C, Landi D, Cecchi E, Chiostri M, Gensini GF, Valente S, Ciaccheri M, Castelli G, Romano SM. Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. Eur J Heart Fail 2011;13:337-346.
35. Schrier RW. Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 2008;1:2-5.
36. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD,Westenbrink BD, Bonventre JV, Voors AA, Hillege HL. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010;96:1297-1302.
37. Kazory A. Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 2010;106:694-700.
38. Gotsman I, Zwas D, Planer D, Admon D, Lotan C, Keren A. The significance of serum urea and renal function in patients with heart failure. Medicine 2010;89: 197-203.
39. Testani JM, Cappola TP, Brensinger CM, Shannon RP, Kimmel SE. Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol 2011;58:375-382.
40. Cerasola G, Nardi E, Palermo A, Mulè G, Cottone S. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol 2011;24:1-10.
41. Tresch DD, McGough MF. Heart failure with normal systolic function: a common disorder in older people. J Am Geriatr Soc 1995;43:1035-1042.
42. Cappola TP, Felker GM, Kao WH, Hare JM, Baughman KL, Kasper EK. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 2002;105:1663-1668.
43. Konig PS, Lhotta K, Kronenberg F, Joannidis M, Herold M. CAPD; a successful treatment in patients suffering from therapy-resistant congestive heart failure. Adv Perit Dial 1991;7:97-101.
44. Del Sindaco D, Pulignano G, Minardi G, Apostoli A, Guerrieri L, Rotoloni M, Petri G, Fabrizi L, Caroselli A, Venusti R, Chiantera A, Giulivi A, Giovannini E, Leggio F. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. J Cardiovasc Med 2007; 8:324-329.
45. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818-827.